Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone plays a big role in heart and nervous system damage caused by inflammation in male rats, suggesting that blocking testosterone production could help manage this condition.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Microneedle Therapy System effectively treats acne, scars, and hair loss safely.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

The enzyme PA-PLA1α is important for proper hair follicle development.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

Tridax procumbens may help treat diabetes.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Overexpressing ATF3 in mice's epithelial cells may lead to oral cancer.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Pitx2 helps outer root sheath cells differentiate but can't start hair growth on its own.

Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

Recognizing macro-TSH is crucial to avoid unnecessary treatments.

Androgens help motor neurons grow by increasing neuritin.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.